Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Drosha–DGCR8 microprocessor complex is a nuclear heterotrimeric assembly essential for the primary step of microRNA (miRNA) biogenesis (NIH, 2020). It consists of one molecule of the Class 2 ribonuclease III enzyme Drosha and two molecules of the RNA-binding protein DGCR8 (DiGeorge syndrome critical region 8) (Wikipedia, 2024). Within the complex, DGCR8 acts as a molecular anchor and ruler, recognizing the junction between the single-stranded and double-stranded regions of primary miRNA (pri-miRNA) transcripts and positioning Drosha to execute a precise endonucleolytic cleavage (UniProt, 2024). This process releases a ~70-nucleotide precursor miRNA (pre-miRNA) hairpin, which is subsequently exported to the cytoplasm for further maturation by Dicer (PubMed, 2011). Beyond miRNA processing, the complex regulates the stability of various messenger RNAs (mRNAs) and small nucleolar RNAs (snoRNAs), often through an auto-regulatory feedback loop where it cleaves its own components' transcripts (NIH, 2012). Dysregulation of the microprocessor complex is linked to numerous pathologies, including various cancers where it can act as either an oncogene or a tumor suppressor, and DiGeorge syndrome, which is characterized by the deletion of the DGCR8 gene (MDPI, 2024). Therapeutic strategies targeting the complex include small molecule inhibitors like acriflavine and enhancers like enoxacin, aimed at modulating miRNA-mediated gene silencing in disease contexts (PubMed, 2019).
Inhibition of endonucleolytic cleavage, enhancement of miRNA processing, and disruption of protein-protein or protein-RNA interactions.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Drosha–DGCR8 microprocessor complex (Microprocessor) (Microprocessor).